(Q41964667)

English

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label,

scientific article published on 18 February 2014

Statements

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, (English)
K Kobayashi
M Takemoto
A Kanatsuka
N Kuribayashi
N Hashimoto
K Sakurai
H Hanaoka
K Ishikawa
S Onishi
K Yokote
SUCCESS Study Group
18 February 2014
761-765

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit